Bharat Biotech Dispatches Covaxin Supplies To 11 Cities

HYDERABAD : Vaccine maker Bharat Biotech has started supplies of Covaxin, the COVID-19 vaccine it has developed in collaboration with the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV).

The first batch of the indigenous vaccines were dispatched by air from Hyderabad to 11 cities, across the country, in the early hours of Wednesday.

This follows receipt of the government purchase order for 55 lakh doses, the company said.

A spokesperson of the company said the purchase order will be executed within a few days, but did not share details of how many doses formed part of the first batch that was shipped on Wednesday.

Of the 55 lakh doses of Covaxin, Bharat Biotech has decided to provide 16.5 lakh doses free of cost to the government. The rest is priced at Rs.295 per dose.

Delhi, Bengaluru, Chennai, Lucknow, Pune, Bhubaneswar, Jaipur, Ganavaram, Guwahati, Patna and Kurukshetra are the cities to which the first batch of vaccines (each vial containing 20 doses) were shipped.

While some shipments have reached the respective cities, others will be delivered later in the evening, a release from the company said.

The company expressed deepest gratitude to the country, all clinical trial volunteers and its partners for making this a “successful and milestone public-private partnership for the development of India’s first COVID19- vaccine.”

Covaxin is an inactivated 2-dose SARS-CoV-2 vaccine, developed and manufactured in the company’s BSL-3 (Bio-Safety Level 3) biocontainment facility, one of its kind in the world, the release said.

Phase III clinical trials for Covaxin are underway since November and involve around 26,000 volunteers across the country. Earlier this month, the Drugs Controller General of India had given Emergency Use Authorisation for the vaccine candidate.

Related Posts

  • Pharma
  • July 3, 2025
  • 49 views
Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Delhi High Court asks DCGI to consult experts on weight-loss drug combinations, addressing concerns over safety and approval process The Delhi High Court asked the Drug Controller General of India…

  • Pharma
  • July 2, 2025
  • 117 views
Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

Nagpur: As ‘Plastic Free July’ begins, experts are raising an alarm over emerging evidence that microplastics — tiny fragments smaller than 5 millimetres — are infiltrating the human body and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

Six held for exchanging bribes to give favourable report to medical colleges

Six held for exchanging bribes to give favourable report to medical colleges

Telangana pharma factory blast: Death toll reaches 44, rain hampers rescue operations

Telangana pharma factory blast: Death toll reaches 44, rain hampers rescue operations